Iguchi, Naohiko https://orcid.org/0000-0003-4382-5902
Isozumi, Noriyoshi
Hattori, Yoshikazu
Imamura, Tomohiro https://orcid.org/0000-0003-2277-9134
Yokoyama, Takeshi https://orcid.org/0000-0002-0299-9140
So, Masatomo https://orcid.org/0000-0002-4815-4995
Nanaura, Hitoki https://orcid.org/0000-0002-0934-7065
Kiriyama, Takao https://orcid.org/0000-0002-2282-0849
Eura, Nobuyuki https://orcid.org/0000-0002-4943-3152
Yamaoka, Minako
Iwasa, Naoki
Shiota, Tomo
Nakanishi, Mari
Konishi, Nanako
Ito, Haruka
Takeuchi, Akihito
Mori, Masashi
Ohki, Shinya
Kumeta, Hiroyuki https://orcid.org/0000-0003-3713-2122
Koga, Hironori
Watabe, Mai
Mabuchi, Takuya https://orcid.org/0000-0001-8253-4273
Kanemura, Shingo https://orcid.org/0000-0002-7012-8179
Okumura, Masaki https://orcid.org/0000-0001-8130-2470
Tanaka, Yoshikazu https://orcid.org/0000-0002-7893-3236
Morishima, Ken
Sugiyama, Masaaki
Ide, Fumika
Matsumura, Hiroyoshi https://orcid.org/0000-0003-0361-3796
Yoshizawa, Takuya
Ota, Ichiro
Suzuki, Naoki https://orcid.org/0000-0001-8880-8554
Aoki, Masashi
Yamashiro, Yoshito
Saio, Tomohide https://orcid.org/0000-0003-3639-7399
Sugie, Kazuma https://orcid.org/0000-0003-0148-4687
Mori, Eiichiro https://orcid.org/0000-0003-0945-196X
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP24wm0425004)
MEXT | Japan Society for the Promotion of Science (JP20H03199)
Takeda Science Foundation
Article History
Received: 9 November 2023
Accepted: 15 September 2025
First Online: 16 October 2025
Competing interests
: EM is the Founder CEO of molmir, Inc.. The remaining authors declare no competing interests.